Centessa Pharmaceuticals (CNTA) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to -$9.7 million.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments rose 9.13% to -$9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.7 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$11.3 million for FY2024, which is 1.96% up from last year.
- As of Q3 2025, Centessa Pharmaceuticals' Other Gross PP&E Adjustments stood at -$9.7 million, which was up 10.02% from -$10.8 million recorded in Q2 2025.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at -$1.3 million during Q2 2022, with a 5-year trough of -$13.9 million in Q1 2023.
- In the last 3 years, Centessa Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$11.3 million in 2024 and averaged -$11.5 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 880.50% in 2023, then grew by 16.13% in 2024.
- Centessa Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$2.8 million in 2022, then plummeted by 304.54% to -$11.5 million in 2023, then climbed by 1.96% to -$11.3 million in 2024, then increased by 9.13% to -$9.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$9.7 million for Q3 2025, versus -$10.8 million for Q2 2025 and -$10.8 million for Q1 2025.